Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Steep Neutrophil Recovery Following Unrelated Bone Marrow Transplantation Is a Major Risk Factor for the Development of Acute Graft-Vs-Host Disease

Takashi Nagayama, MD, Shin-ichiro Fujiwara, MD PhD, Hirotomo Nakashima, MD, Shinichiro Kawaguchi, MD, Shoko Ito, MD, Kiyomi Mashima, MD, Kento Umino, MD, Daisuke Minakata, MD, Hirofumi Nakano, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Chihiro Yamamoto, MD PhD, Masahiro Ashizawa, MD, Kaoru Hatano, MD PhD, Kazuya Sato, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2019) 134 (Supplement_1): 5686.

https://doi.org/10.1182/blood-2019-122537

Published: 2019

Journal Articles

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Yasufumi Kawasaki, MD PhD, Kazuya Sato, MDPhD, Hirofumi Nakano, MD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 5676.

https://doi.org/10.1182/blood-2018-99-111773

Published: 2018

Journal Articles

Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd

Hirofumi Nakano, MD, Kazuya Sato, MD PhD, Hiroko Hayakawa, PhD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Kaoru Morita, MD PhD, Ryoko Yamasaki, MD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MD PhD, Yoshinobu Kanda, MD PhD

Blood (2018) 132 (Supplement 1): 3320.

https://doi.org/10.1182/blood-2018-99-110011

Published: 2018

Journal Articles

Recipient Hematopoietic, but Not Non-Hematopoietic, Antigen-Presenting Cells Are Indispensable for CD4+ T-Cell-Mediated Xenogeneic Graft-Versus-Host Disease

Yasufumi Kawasaki, Kazuya Sato, MDPhD, Hiroko Hayakawa, PhD, Norihito Takayama, PhD, Hirofumi Nakano, MD, Kiyomi Mashima, MD, Daisuke Minakata, MD, Ryoko Yamasaki, MD, Kaoru Morita, MD PhD, Masahiro Ashizawa, MD, Chihiro Yamamoto, MD PhD, Kaoru Hatano, MD PhD, Shin-ichiro Fujiwara, MD PhD, Iekuni Oh, MD PhD, Ken Ohmine, MD PhD, Kazuo Muroi, MDPhD, Yoshinobu Kanda, MD PhD

Blood (2017) 130 (Supplement 1): 4441.

https://doi.org/10.1182/blood.V130.Suppl_1.4441.4441

Published: 2017

Journal Articles

Engineering of CD19-CAR T Cells from Non-Hodgkin Lymphoma Patients in a Closed System in Combination with Retronectin/OKT3 Stimulation

Hideto Chono, PhD, Kenichi Tahara, PhD, Ikuei Nukaya, PhD, Junichi Mineno, PhD, Eisuke Uehara, MD PhD, Tomonori Tsukahara, PhD, Ken Ohmine, MD PhD, Keiya Ozawa, MD PhD, Kazutoh Takesako, PhD

Blood (2014) 124 (21): 2446.

https://doi.org/10.1182/blood.V124.21.2446.2446

Published: 2014

Journal Articles

“Incidental Carcinomas” Detected by PET/CT Scans In the Patients with Malignant Lymphoma: A Single-Center Experience with 363 Patients

Kazuya Sato, MD, PhD, Katsutoshi Ozaki, MD, PhD, Tomohiro Matsuyama, MD, Ken Ohmine, MD, PhD, Takahiro Suzuki, MD, PhD, Masaki Mori, MD, PhD, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, MD, PhD

Blood (2010) 116 (21): 4132.

https://doi.org/10.1182/blood.V116.21.4132.4132

Published: 2010

Journal Articles

Vincristine Potentiates the Anti-Leukemia Effect of the Aurora Kinase Inhibitor VE-465 by Enhancing Apoptosis in Myeloid Leukemia Cells.

Ken Ohmine, MD, PhD, Tadashi Nagai, MD, PhD, Kozue Yoshida, MD, PhD, Shin-ichiro Fujiwara, MD, PhD, Mitsuyo Uesawa, MD, Chihiro Sakurai, MD, Keiya Ozawa, MD, PhD

Blood (2009) 114 (22): 2762.

https://doi.org/10.1182/blood.V114.22.2762.2762

Published: 2009

Journal Articles

Heme-Mediated Change in Sensitivity to Anti-Leukemia Reagents in BCR/ABL-Positive Cell Lines.

Ken Ohmine, MD, Tadashi Nagai, MD, Satoru Kikuchi, MD, Takuji Miyoshi, MD, Makiko Nakamura, B.Agr, Takahito Kondo, MD, Norio Komatsu, MD, Kazumichi Furuyama, MD, Keiya Ozawa, MD

Blood (2005) 106 (11): 4437.

https://doi.org/10.1182/blood.V106.11.4437.4437

Published: 2005

Journal Articles

Cloning and Characterization of a Tipifarnib-Resistant BCR/ABL-Positive Cell Line, K562/RR.

Takuji Miyoshi, MD, Tadashi Nagai, MD, Ken Ohmine, MD, Satoru Kikuchi, MD, Makiko Nakamura, B.Agr, Keiya Ozawa, MD

Blood (2005) 106 (11): 1527.

https://doi.org/10.1182/blood.V106.11.1527.1527

Published: 2005

Journal Articles

Heme Affects Sensitivity to Imatinib through Regulation of Nrf2 Activity in BCR/ABL-Positive Cell Lines.

Takuji Miyoshi, MD, Tadashi Nagai, MD PhD, Makiko Nakamura, Ken Ohmine, MD PhD, Hiroyoshi Fujita, MD PhD, Shigeru Taketani, PhD, Norio Komatsu, MD PhD, Keiya Ozawa, MD PhD

Blood (2004) 104 (11): 2092.

https://doi.org/10.1182/blood.V104.11.2092.2092

Published: 2004

NARROW

Steep Neutrophil Recovery Following Unrelated Bone Marrow Transplantation Is a Major Risk Factor for the Development of Acute Graft-Vs-Host Disease

Comprehensive Analysis of Chemokines in Host Organs and Their Corresponding Receptors on Donor T-Cells in Xenogeneic Gvhd Model

Alloantigen-Activated Human T-Cells Increase Extracellular Fatty Acid Uptake and Intracellular Lipid Metabolism during Xenogeneic Gvhd

Recipient Hematopoietic, but Not Non-Hematopoietic, Antigen-Presenting Cells Are Indispensable for CD4+ T-Cell-Mediated Xenogeneic Graft-Versus-Host Disease

Engineering of CD19-CAR T Cells from Non-Hodgkin Lymphoma Patients in a Closed System in Combination with Retronectin/OKT3 Stimulation

“Incidental Carcinomas” Detected by PET/CT Scans In the Patients with Malignant Lymphoma: A Single-Center Experience with 363 Patients

Vincristine Potentiates the Anti-Leukemia Effect of the Aurora Kinase Inhibitor VE-465 by Enhancing Apoptosis in Myeloid Leukemia Cells.

Heme-Mediated Change in Sensitivity to Anti-Leukemia Reagents in BCR/ABL-Positive Cell Lines.

Cloning and Characterization of a Tipifarnib-Resistant BCR/ABL-Positive Cell Line, K562/RR.

Heme Affects Sensitivity to Imatinib through Regulation of Nrf2 Activity in BCR/ABL-Positive Cell Lines.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only